BSTC
$64.31
Biospecifics Tech Cp
$1.65
2.63%
BSTC
Earnings Whisper ®
N/A
2nd Quarter June 2020
Consensus:  ($0.05)
Revenue:  $2.06 Mil
Friday
Aug 14
After the close
Score
Grade
Tweet Share Watch
Tweet Share Watch

What do you expect when BSTC reports earnings?
Beat
Meet
Miss

Where is BSTC's stock price going from here?
Up
Flat
Down
Stock chart of BSTC
Analysts
Summary of analysts' recommendations for BSTC
Score
Grade
Pivots
Resistance
-
-
-

-

Support
-
-
-
Tweet
Growth
Description
BIOSPECIFICS TECHNOLOGIES is engaged in the business of producing and licensing, for sale by other, a U.S. Food and Drug Administration (FDA) approved enzyme derived from collagenase, named Collagenase ABC, and researching, developing and clinically testing additional products derived therefrom for potential use as pharmaceuticals.